Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	cell morphogenesis	CLSTN3 LZTS3 MYCBP2 TRPC6 CUL7 DSCAML1 POF1B FAT1 HMCN2 YAP1 SKOR2 COBL NOTCH3 C15orf62 APBB1 APC SHH SPAG6 EDN2 WDR47 FAM171A1 FRY IGHM TET1 LRP4 ROBO1 PRKDC SCRIB RAPGEF2 CDH3	4.82e-06	1194	211	30	GO:0000902
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	CLSTN3 DSCAML1 FAT1 HMCN2 PCDH11X IGSF11 NECTIN3 TENM3 ROBO1 CDH3	2.38e-05	187	211	10	GO:0007156
Domain	ARM-like	MROH5 CUL7 NCAPG2 MMS19 HEATR5B KPNA2 DNAJC13 RTTN APC HUWE1 SPAG6 ARID2 PRKDC	9.93e-06	270	206	13	IPR011989
Domain	ZINC_FINGER_C2H2_2	BNC2 ZNF71 ZNF469 ZNF780A ZNF644 ZNF483 ZNF778 ZNF766 ZFP69B ZNF567 ZBTB2 ZFAT ZNF596 ZBTB26 DZIP1 PRDM4 HIVEP3 ZSCAN20 ARID2 ZNF566 PRDM15 PRDM6 ZNF654	1.61e-05	775	206	23	PS50157
Domain	ZINC_FINGER_C2H2_1	BNC2 ZNF71 ZNF469 ZNF780A ZNF644 ZNF483 ZNF778 ZNF766 ZFP69B ZNF567 ZBTB2 ZFAT ZNF596 ZBTB26 DZIP1 PRDM4 HIVEP3 ZSCAN20 ARID2 ZNF566 PRDM15 PRDM6 ZNF654	1.68e-05	777	206	23	PS00028
Domain	Znf_C2H2-like	BNC2 ZNF71 ZNF469 ZNF780A ZNF644 ZNF483 ZNF778 ZNF766 ZFP69B ZNF567 ZBTB2 ZFAT ZNF596 ZBTB26 DZIP1 PRDM4 HIVEP3 ZSCAN20 ARID2 ZNF566 PRDM15 PRDM6 ZNF654	2.46e-05	796	206	23	IPR015880
Domain	ARM-type_fold	MROH5 CUL7 NCAPG2 MMS19 HEATR5B KPNA2 MYBBP1A DNAJC13 RTTN APC HUWE1 SPAG6 ARID2 PRKDC	2.54e-05	339	206	14	IPR016024
Domain	zf-C2H2	BNC2 ZNF71 ZNF469 ZNF780A ZNF644 ZNF483 ZNF778 ZNF766 ZFP69B ZNF567 ZBTB2 ZFAT ZNF596 ZBTB26 DZIP1 PRDM4 HIVEP3 ZSCAN20 ZNF566 PRDM15 PRDM6	2.84e-05	693	206	21	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF71 ZNF469 ZNF780A ZNF644 ZNF483 ZNF778 ZNF766 ZFP69B ZNF567 ZBTB2 ZFAT ZNF596 ZBTB26 DZIP1 PRDM4 HIVEP3 ZSCAN20 ZNF566 PRDM15 PRDM6 ZNF654	2.90e-05	694	206	21	IPR013087
Domain	Znf_C2H2	BNC2 ZNF71 ZNF469 ZNF780A ZNF644 ZNF483 ZNF778 ZNF766 ZFP69B ZNF567 ZBTB2 ZFAT ZNF596 ZBTB26 DZIP1 PRDM4 HIVEP3 ZSCAN20 ARID2 ZNF566 PRDM15 PRDM6 ZNF654	2.93e-05	805	206	23	IPR007087
Domain	ZnF_C2H2	BNC2 ZNF71 ZNF469 ZNF780A ZNF644 ZNF483 ZNF778 ZNF766 ZFP69B ZNF567 ZBTB2 ZFAT ZNF596 ZBTB26 DZIP1 PRDM4 HIVEP3 ZSCAN20 ARID2 ZNF566 PRDM15 PRDM6 ZNF654	3.11e-05	808	206	23	SM00355
Domain	-	MROH5 CUL7 NCAPG2 MMS19 HEATR5B KPNA2 DNAJC13 RTTN APC SPAG6 PRKDC	3.73e-05	222	206	11	1.25.10.10
Domain	-	ZNF71 ZNF780A ZNF644 ZNF483 ZNF778 ZNF766 ZFP69B ZNF567 ZBTB2 ZFAT ZNF596 ZBTB26 DZIP1 PRDM4 HIVEP3 ZSCAN20 ZNF566 PRDM15 PRDM6 ZNF654	6.58e-05	679	206	20	3.30.160.60
Domain	Spy1	SPDYE2B SPDYE4 SPDYE6	2.04e-04	11	206	3	PF11357
Domain	Speedy	SPDYE2B SPDYE4 SPDYE6	2.04e-04	11	206	3	IPR020984
Pathway	WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88	IRF3 TLR6 IKBKE TLR1 TLR3	9.67e-06	31	133	5	M39573
Pathway	KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY	IRF3 IKBKE TLR3	6.62e-05	9	133	3	M47451
Pathway	PID_TOLL_ENDOGENOUS_PATHWAY	TLR6 CD14 TLR1 TLR3	6.95e-05	24	133	4	M264
Pathway	REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES	IRF3 NUP210 IL17RA KPNA2 SIKE1 IKBKE TLR1	1.89e-04	126	133	7	M45009
Pathway	WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION	IRF3 TLR6 IKBKE TLR3	1.96e-04	31	133	4	M39859
Pathway	REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7	IRF3 IKBKE TLR3	2.19e-04	13	133	3	M27884
Pathway	REACTOME_DISEASES_OF_IMMUNE_SYSTEM	TLR6 CD14 TLR1 TLR3	2.22e-04	32	133	4	M27428
Pathway	REACTOME_RSV_HOST_INTERACTIONS	CDK19 IRF3 TLR6 MED13 CD14 TLR3	3.26e-04	98	133	6	M48247
Pathway	REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY	IRF3 SIKE1 IKBKE	3.44e-04	15	133	3	M953
Pathway	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	IRF3 TLR6 CD14 IKBKE TLR1 TLR3	4.04e-04	102	133	6	M3261
Pathway	WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER	EXPH5 UNC13D TBC1D10A	4.20e-04	16	133	3	M39391
Pathway	WP_TOLLLIKE_RECEPTOR_SIGNALING	IRF3 TLR6 CD14 IKBKE TLR1 TLR3	4.26e-04	103	133	6	M39434
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DOCK4 MYCBP2 EXPH5 SPTBN1 HJURP MAST2 YAP1 COBL BOD1L1 AGAP3 USP53 APBB1 APC DZIP1 FAM171A1 VPS13D IKBKE TET1 TANC1 SCRIB RAPGEF2 KIF13A	2.17e-08	861	214	22	36931259
Pubmed	Defining the membrane proteome of NK cells.	HSP90B1 SERBP1 GPAA1 ELMOD2 MYCBP2 AUP1 HLA-DQB1 PSMC4 F5 NCAPG2 NUP210 MMS19 HEATR5B PIGO MED13 KPNA2 MYBBP1A DNAJC13 HUWE1 PRKRA MARF1 PRKDC STARD3NL YME1L1 PSD4	7.09e-08	1168	214	25	19946888
Pubmed	TLR2 activation inhibits embryonic neural progenitor cell proliferation.	IRF3 TLR6 CD14 TLR1	9.57e-08	8	214	4	20456021
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MYCBP2 VWA8 MAST2 FAT1 COBL TTC5 MED13 AGAP3 NRF1 RTTN AMBRA1 PAPLN HUWE1 PIKFYVE HIVEP3 MYOF RPAP1 LRP4 PDCD11 ZFYVE26 TANC1 PRKDC SPEN	3.99e-07	1105	214	23	35748872
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	EXPH5 CUL7 ELFN2 NUP210 ZBTB2 ZBTB26 ARHGEF15 PIKFYVE HIVEP3 MYOF VPS13D USF3 CMIP ARID2 TLR1	4.84e-07	493	214	15	15368895
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	A2M HSP90B1 AUP1 SPTBN1 PSMC4 POF1B NUP210 MMS19 PZP KPNA2 RGPD2 HUWE1 CCAR2 PRKDC SCRIB CDH3 YME1L1	6.35e-07	647	214	17	26618866
Pubmed	Murine cerebral malaria development is independent of toll-like receptor signaling.	TLR6 CD14 TLR1 TLR3	6.64e-07	12	214	4	17456769
Pubmed	Polymorphisms in interleukin-1 receptor-associated kinase 4 are associated with total serum IgE.	TLR6 CD14 TLR1 TLR3	6.64e-07	12	214	4	19254290
Pubmed	B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection.	HLA-DQB2 IGHM PRKDC	9.15e-07	4	214	3	17114442
Pubmed	YAP/TEAD1 Complex Is a Default Repressor of Cardiac Toll-Like Receptor Genes.	TLR6 YAP1 TLR1 TLR3	1.33e-06	14	214	4	34206257
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	HSP90B1 CLSTN3 MYCBP2 SPTBN1 DSCAML1 MED13 AGAP3 APBB1 APC DNAAF9 DZIP1 HUWE1 PRDM4 STAMBP PRKRA WDR47 FRY LRP4 ROBO1 PRKDC SCRIB RAPGEF2 YME1L1 SNX5	1.49e-06	1285	214	24	35914814
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	HSP90B1 CLSTN3 GPAA1 MYCBP2 NCAPG2 DMXL1 RINT1 FAT1 ADSL NUP210 MICA PIGO NOTCH3 COL7A1 TMEM201 NECTIN3 MYOF TENM3 LRP4 ROBO1 SCRIB OSMR SNX5	1.65e-06	1201	214	23	35696571
Pubmed	The protein interaction landscape of the human CMGC kinase group.	A2M LZTS3 CDK19 CUL7 ADPRH MED13 KPNA2 SEMG2 MYBBP1A APC HUWE1 PRKRA FRY ALKBH3 PDCD11 SCRIB YME1L1	1.68e-06	695	214	17	23602568
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	A2M HSP90B1 HSP90B2P SPTBN1 CCDC177 F5 DMXL1 NFRKB PZP MYBBP1A APC PRKRA FRY RAPGEF2	1.70e-06	475	214	14	31040226
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	IRF3 CUL7 RINT1 AGL ZNF644 MMS19 NOTCH3 KPNA2 ZBTB2 NRF1 SMPD4 HUWE1 NR3C1 WDR47 CCAR2 SCRIB SPEN PRDM15 PRDM6	1.73e-06	857	214	19	25609649
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	HSP90B1 MYCBP2 AUP1 VWA8 SPTBN1 PSMC4 NCAPG2 DMXL1 RINT1 ZNF644 NUP210 MYBBP1A TMEM201 DNAJC13 APBB1 SMPD4 DZIP1 NR3C1 FAM171A1 RPAP1 PDCD11 ROBO1 TANC1 SCRIB YME1L1 SNX5	1.79e-06	1487	214	26	33957083
Pubmed	MyD88- and Bruton's tyrosine kinase-mediated signals are essential for T cell-independent pathogen-specific IgM responses.	TLR6 CD14 TLR1 TLR3	1.80e-06	15	214	4	17339472
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SERBP1 MYCBP2 YAP1 NFRKB BOD1L1 KPNA2 MYBBP1A APBB1 HUWE1 ARID2 TET1 PDCD11 PRKDC SCRIB SPEN	1.84e-06	549	214	15	38280479
Pubmed	Association between toll-like receptors/CD14 gene polymorphisms and inflammatory bowel disease in Korean population.	TLR6 CD14 TLR1	2.28e-06	5	214	3	22219617
Pubmed	NF-κB is activated from endosomal compartments in antiphospholipid antibodies-treated human monocytes.	TLR6 CD14 TLR1	2.28e-06	5	214	3	24612386
Pubmed	TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis.	TLR6 CD14 TLR1	2.28e-06	5	214	3	19362712
Pubmed	Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting.	TLR6 CD14 TLR1	2.28e-06	5	214	3	16880211
Pubmed	Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses.	TLR6 CD14 TLR1	2.28e-06	5	214	3	15294986
Pubmed	Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity.	HLA-DQB2 IL17RA IGHM	2.28e-06	5	214	3	20089698
Pubmed	Natural selection in the TLR-related genes in the course of primate evolution.	TLR6 CD14 TLR1 TLR3	2.39e-06	16	214	4	18810425
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	HSP90B1 SERBP1 MYCBP2 AUP1 HLA-DQB1 HJURP PSMC4 NCAPG2 ADSL AGL NUP210 MMS19 KPNA2 RGPD2 MYBBP1A TMEM201 AMBRA1 SMPD4 HUWE1 CCAR2 PRKDC SCRIB YME1L1	3.51e-06	1257	214	23	37317656
Pubmed	NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction.	IRF3 IKBKE TLR3	4.53e-06	6	214	3	17142768
Pubmed	Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.	TLR6 TLR1 TLR3	4.53e-06	6	214	3	10426995
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	MYCBP2 VWA8 AGL NUP210 MYBBP1A DNAJC13 PDCD11 PRKDC SCRIB	4.94e-06	202	214	9	24639526
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	A2M HSP90B1 SERBP1 VWA8 SPTBN1 NUP210 COBL KPNA2 FLG SMPD4 C1orf167 NUDT13 ARHGEF15 MYOF ROS1 KIF13A YME1L1	4.96e-06	754	214	17	35906200
Pubmed	Hydroxypropyl-β-cyclodextrin spikes local inflammation that induces Th2 cell and T follicular helper cell responses to the coadministered antigen.	IRF3 TLR6 TLR1 TLR3	5.02e-06	19	214	4	25681338
Pubmed	Proteome-wide analysis of phospho-regulated PDZ domain interactions.	YAP1 HEATR5B APC TANC1 SCRIB	5.95e-06	42	214	5	30126976
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	HSP90B1 EXPH5 SECISBP2 TMEM201 APBB1 APC SMPD4 TENM1 TANC1 SCRIB	5.99e-06	263	214	10	34702444
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	HSP90B1 HSP90B2P EXPH5 PSMC4 COBL BOD1L1 TLR3 SCRIB SPEN	6.26e-06	208	214	9	33230847
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	DOCK4 LZTS3 PSMC4 MAST2 DSCAML1 POF1B FAT1 ADSL SKOR2 ZNF483 MMS19 FLG APC SPAG6 PRDM15 LRIF1	6.58e-06	689	214	16	36543142
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	FILIP1 MYCBP2 SPTBN1 YAP1 ZNF644 NFRKB MED13 MYBBP1A DNAJC13 IQCN HUWE1 MYOF RPAP1 CCAR2 PRKDC SCRIB SPEN	6.98e-06	774	214	17	15302935
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	AUP1 DMXL1 FAT1 AGAP3 MYBBP1A DNAJC13 APBB1 APC HUWE1 TENM3 ROBO1 CCAR2 PRKDC SCRIB RAPGEF2 DEPDC7 SPEN	7.34e-06	777	214	17	35844135
Pubmed	Telomerase-deficient mice exhibit bone loss owing to defects in osteoblasts and increased osteoclastogenesis by inflammatory microenvironment.	TLR6 CD14 IKBKE PRELP PRKDC	7.52e-06	44	214	5	21308778
Pubmed	IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.	IRF3 IKBKE TLR3	7.90e-06	7	214	3	12692549
Pubmed	Polymorphisms of toll like receptors in the genetics of severe RSV associated diseases.	TLR6 TLR1 TLR3	7.90e-06	7	214	3	18776592
Pubmed	Isolated Toll-like receptor transmembrane domains are capable of oligomerization.	TLR6 TLR1 TLR3	7.90e-06	7	214	3	23155421
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	SPTBN1 CDK19 POF1B BOD1L1 MED13 MYOF MARF1 PDCD11 PRKDC ZNF654	8.04e-06	272	214	10	31010829
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DOCK4 CLSTN3 CDK19 ZNF644 COBL BOD1L1 WDR47 RPAP1 TENM3 CCAR2 SCRIB SPEN	9.47e-06	407	214	12	12693553
Pubmed	The association of innate immune response gene polymorphisms and puerperal group A streptococcal sepsis.	TLR6 F5 CD14 TLR1	1.13e-05	23	214	4	20207250
Pubmed	A human MAP kinase interactome.	HSP90B1 EXPH5 SPTBN1 KIAA1549L COBL USP53 APC STAMBP USF3 ARID2 ROBO1 PRKDC RAPGEF2	1.13e-05	486	214	13	20936779
Pubmed	Molecular determinants of crosstalk between nuclear receptors and toll-like receptors.	IRF3 NR3C1 TLR3	1.26e-05	8	214	3	16143103
Pubmed	Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response.	TLR6 TLR1 TLR3	1.26e-05	8	214	3	20100933
Pubmed	Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens.	TLR6 TLR1 TLR3	1.26e-05	8	214	3	11561001
Pubmed	Hippo signalling governs cytosolic nucleic acid sensing through YAP/TAZ-mediated TBK1 blockade.	IRF3 YAP1 IKBKE	1.26e-05	8	214	3	28346439
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	AUP1 EXPH5 FAT1 PCDH11X COBL USP53 APBB1 SMPD4 NECTIN3 SLC6A9 TBC1D10A TANC1 SCRIB PSD4	1.33e-05	569	214	14	30639242
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	AUP1 HJURP PSMC4 MAST2 ZNF644 APC AMBRA1 HUWE1 RAPGEF2	1.50e-05	232	214	9	25515538
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	HJURP ZNF469 YAP1 KPNA2 C15orf62 USP53 BLZF1 PRDM4 USF3 ARID2 CCDC87 SPEN	1.63e-05	430	214	12	35044719
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	VWA8 CUL7 MAST2 DSCAML1 MED13 VPS13D LRP4	1.69e-05	130	214	7	12421765
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MAST2 DSCAML1 DNAJC13 HUWE1 TANC1 RAPGEF2	1.69e-05	87	214	6	12465718
Pubmed	Gene polymorphisms of Toll-like and related recognition receptors in relation to the vaginal carriage of Gardnerella vaginalis and Atopobium vaginae.	TLR6 CD14 TLR1	1.88e-05	9	214	3	19200604
Pubmed	A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis.	APC CD14 PRKDC	1.88e-05	9	214	3	25362351
Pubmed	Murine fertility and spermatogenesis are independent of the testis-specific Spdye4a gene.	SPDYE2B SPDYE4 SPDYE6	1.88e-05	9	214	3	36272447
Pubmed	Regulation of angiogenesis, mural cell recruitment and adventitial macrophage behavior by Toll-like receptors.	TLR6 TLR1 TLR3	1.88e-05	9	214	3	24091496
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	HSP90B1 MYCBP2 AUP1 VWA8 PSMC4 CUL7 RINT1 ADSL ZNF644 SECISBP2 MMS19 MYBBP1A APBB1 SMPD4 HUWE1 SLC25A51 PIKFYVE VPS13D RPAP1 ARID2 PDCD11 CCAR2 TANC1 YME1L1	1.90e-05	1496	214	24	32877691
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	DOCK4 PSMC4 CUL7 YAP1 ZNF644 SECISBP2 APC HUWE1 NR3C1 PIKFYVE ARID2 TANC1 SPEN LRIF1	1.91e-05	588	214	14	38580884
Pubmed	Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation.	TLR6 TLR1 TLR3	2.67e-05	10	214	3	20227302
Pubmed	[Expression of toll-like receptors in human epidermal keratinocytes].	TLR6 TLR1 TLR3	2.67e-05	10	214	3	18686608
Pubmed	Toll-like receptors.	TLR6 TLR1 TLR3	2.67e-05	10	214	3	11782555
Pubmed	Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis.	TLR6 CD14 TLR1	2.67e-05	10	214	3	19122641
Pubmed	A family of human receptors structurally related to Drosophila Toll.	TLR6 TLR1 TLR3	2.67e-05	10	214	3	9435236
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	DOCK4 HSP90B1 HSP90B2P SERBP1 LZTS3 MYCBP2 VWA8 SPTBN1 PSMC4 ELFN2 AGAP3 RGPD2 APBB1 APC HUWE1 SLC25A51 PRKRA WDR47 TENM1 SLC25A52	2.82e-05	1139	214	20	36417873
Pubmed	Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells.	GGT3P NOTCH3 NECTIN3 GGT2P	2.93e-05	29	214	4	22424930
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	HSP90B1 MYCBP2 SPTBN1 PSMC4 CUL7 RINT1 NUP210 KPNA2 MYBBP1A DNAJC13 TNS2 SMPD4 HUWE1 FAM171A1 ROBO1 CCAR2 TANC1 SCRIB YME1L1	2.96e-05	1049	214	19	27880917
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	BNC2 KIF24 MED13 KPNA2 DNAJC13 SLC25A51 VPS13D TENM3 ARID2 TET1 SLC25A52 TANC1 SNX5	3.15e-05	536	214	13	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	BNC2 KIF24 MED13 KPNA2 DNAJC13 SLC25A51 VPS13D TENM3 ARID2 TET1 SLC25A52 TANC1 SNX5	3.27e-05	538	214	13	10512203
Pubmed	Sequence- and target-independent angiogenesis suppression by siRNA via TLR3.	IRF3 PRKRA TLR3	3.65e-05	11	214	3	18368052
Pubmed	Identification of a key pathway required for the sterile inflammatory response triggered by dying cells.	TLR6 TLR1 TLR3	3.65e-05	11	214	3	17572686
Pubmed	Toll-like receptors.	TLR6 TLR1 TLR3	3.65e-05	11	214	3	18394314
Pubmed	Essential role of the molecular chaperone gp96 in regulating melanogenesis.	HSP90B1 HSP90B2P	3.77e-05	2	214	2	24024552
Pubmed	Species-specific recognition of Aspergillus fumigatus by Toll-like receptor 1 and Toll-like receptor 6.	TLR6 TLR1	3.77e-05	2	214	2	22315281
Pubmed	Evidence that glycoprotein 96 (B2), a stress protein, functions as a Th2-specific costimulatory molecule.	HSP90B1 HSP90B2P	3.77e-05	2	214	2	12244140
Pubmed	PRDM4 mediates YAP-induced cell invasion by activating leukocyte-specific integrin β2 expression.	YAP1 PRDM4	3.77e-05	2	214	2	29669796
Pubmed	[DISTRIBUTION OF TWO-LOCUS HAPLOTYPES OF MICROBIAL COMPONENT SENSOR GENES TLR1 AND TLR6 IN MAJOR POPULATIONS OF SOUTH URALS].	TLR6 TLR1	3.77e-05	2	214	2	26470427
Pubmed	Epigenetic remodelling licences adult cholangiocytes for organoid formation and liver regeneration.	YAP1 TET1	3.77e-05	2	214	2	31685987
Pubmed	Association of human TLR1 and TLR6 deficiency with altered immune responses to BCG vaccination in South African infants.	TLR6 TLR1	3.77e-05	2	214	2	21852947
Pubmed	YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis.	YAP1 TET1	3.77e-05	2	214	2	35835915
Pubmed	Chaperone gp96 mediates ER-α36 cell membrane expression.	HSP90B1 HSP90B2P	3.77e-05	2	214	2	26396174
Pubmed	5'-structural analysis of genes encoding polymorphic antigens of chemically induced tumors.	HSP90B1 HSP90B2P	3.77e-05	2	214	2	2438686
Pubmed	Genetic Polymorphism in Toll-Like Receptor 3 and Interferon Regulatory Factor 3 in Hepatitis C Virus-Infected Patients: Correlation with Liver Cirrhosis.	IRF3 TLR3	3.77e-05	2	214	2	36048530
Pubmed	Immunobiotic Strains Modulate Toll-Like Receptor 3 Agonist Induced Innate Antiviral Immune Response in Human Intestinal Epithelial Cells by Modulating IFN Regulatory Factor 3 and NF-κB Signaling.	IRF3 TLR3	3.77e-05	2	214	2	31333667
Pubmed	Genetic ancestry effects on the distribution of toll-like receptors (TLRs) gene polymorphisms in a population of the Atlantic Forest, São Paulo, Brazil.	TLR6 TLR1	3.77e-05	2	214	2	29175392
Pubmed	Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability.	HSP90B1 TLR1	3.77e-05	2	214	2	11584270
Pubmed	Chromosomal assignment of the gene encoding the mouse tumor rejection antigen gp96.	HSP90B1 HSP90B2P	3.77e-05	2	214	2	3410508
Pubmed	Glycoprotein (GP)96 Is Essential for Maintaining Intestinal Epithelial Architecture by Supporting Its Self-Renewal Capacity.	HSP90B1 HSP90B2P	3.77e-05	2	214	2	36516930
Pubmed	Short-interfering RNAs induce retinal degeneration via TLR3 and IRF3.	IRF3 TLR3	3.77e-05	2	214	2	21988875
Pubmed	The Roles of TLR Gene Polymorphisms in Atherosclerosis: A Systematic Review and Meta-Analysis of 35,317 Subjects.	TLR6 TLR1	3.77e-05	2	214	2	28474755
Pubmed	B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection.	HLA-DQB2 IGHM	3.77e-05	2	214	2	16670323
Pubmed	The role of Toll-like receptor polymorphisms in acute pancreatitis occurrence and severity.	TLR6 TLR3	3.77e-05	2	214	2	25423559
Pubmed	gp96 expression in neutrophils is critical for the onset of Escherichia coli K1 (RS218) meningitis.	HSP90B1 HSP90B2P	3.77e-05	2	214	2	22109526
Pubmed	Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function.	HSP90B1 HSP90B2P	3.77e-05	2	214	2	15128793
Pubmed	SLC25A51 is a mammalian mitochondrial NAD+ transporter.	SLC25A51 SLC25A52	3.77e-05	2	214	2	32906142
Pubmed	Targeted deletion of ER chaperone GRP94 in the liver results in injury, repopulation of GRP94-positive hepatocytes, and spontaneous hepatocellular carcinoma development in aged mice.	HSP90B1 HSP90B2P	3.77e-05	2	214	2	25220589
Pubmed	Gp96 deficiency affects TLR4 functionality and impairs ERK and p38 phosphorylation.	HSP90B1 HSP90B2P	3.77e-05	2	214	2	29447283
Pubmed	Visualization of conformational transition of GRP94 in solution.	HSP90B1 HSP90B2P	3.77e-05	2	214	2	37949474
Pubmed	Bap, a biofilm matrix protein of Staphylococcus aureus prevents cellular internalization through binding to GP96 host receptor.	HSP90B1 HSP90B2P	3.77e-05	2	214	2	22876182
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	BNC2 ZNF71 ZNF469 ZNF780A ZNF483 ZNF778 ZNF766 ZFP69B ZNF567 ZBTB2 ZFAT ZNF596 ZBTB26 PRDM4 HIVEP3 ZSCAN20 ZNF566 PRDM15 PRDM6	1.46e-06	718	134	19	28
GeneFamily	Fibronectin type III domain containing	ELFN2 DSCAML1 COL7A1 CSF3R ROBO1 ROS1 LRRN4 OSMR	2.56e-05	160	134	8	555
GeneFamily	CD molecules\|Toll like receptors	TLR6 TLR1 TLR3	4.60e-05	10	134	3	948
GeneFamily	Speedy/RINGO cell cycle regulator family	SPDYE2B SPDYE4 SPDYE6	8.34e-05	12	134	3	756
GeneFamily	Zinc fingers C2H2-type\|PR/SET domain family	PRDM4 PRDM15 PRDM6	2.51e-04	17	134	3	1197
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	DSCAML1 HMCN2 PAPLN IGSF11 NECTIN3 ROBO1	1.28e-03	161	134	6	593
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	A2M PZP	1.90e-03	9	134	2	1234
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	ELFN2 SH3RF2 PCDH11X APC PPP1R3A MARF1	2.31e-03	181	134	6	694
GeneFamily	C1-set domain containing	HLA-DQB1 HLA-DQB2 MICA	3.70e-03	42	134	3	591
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	KPNA2 APC SPAG6	3.96e-03	43	134	3	409
GeneFamily	CD molecules\|Gamma-glutamyltransferases	GGT3P GGT2P	4.03e-03	13	134	2	564
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF24 KIF2B KIF13A	4.79e-03	46	134	3	622
GeneFamily	INO80 complex \|SRCAP complex	INO80D NFRKB	5.37e-03	15	134	2	595
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	A2M BNC2 TRPC6 INPP4B YAP1 MAMDC2 USP53 TENM3 ROBO1 TANC1 PRDM6	2.81e-09	195	213	11	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M BNC2 TRPC6 INPP4B MAMDC2 USP53 COL6A2 TENM3 PRELP ROBO1 PRDM6	3.67e-09	200	213	11	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BNC2 MAMDC2 PCDH11X COL6A2 PAPLN KCNT2 DACH2 PRELP LRP4 DEPDC7	1.83e-08	181	213	10	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	A2M BNC2 INPP4B YAP1 NOTCH3 USP53 COL6A2 FRY KCNT2 PRDM6	2.49e-08	187	213	10	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 TRPC6 FAT1 PZP NOTCH3 COL6A2 MYOF KCNT2 PRELP PRDM6	2.76e-08	189	213	10	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	A2M INPP4B ST6GAL2 HMCN2 YAP1 NOTCH3 MYOF FRY KCNT2 KIF13A	2.76e-08	189	213	10	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRPC6 FAT1 PZP NOTCH3 COL6A2 MYOF KCNT2 PRELP LRP4 PRDM6	3.05e-08	191	213	10	08042952431ca1a6fd7dfc13f36eb28643979598
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	A2M BNC2 TRPC6 INPP4B MAMDC2 USP53 COL6A2 TENM3 ROBO1 PRDM6	3.20e-08	192	213	10	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FILIP1 INPP4B COL6A2 KCNT2 TENM3 DACH2 ROBO1 TANC1 OSMR	3.53e-08	194	213	10	90efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FILIP1 INPP4B COL6A2 KCNT2 TENM3 DACH2 ROBO1 TANC1 OSMR	3.53e-08	194	213	10	df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	A2M BNC2 INPP4B MAMDC2 USP53 COL6A2 TENM3 PRELP ROBO1 PRDM6	4.28e-08	198	213	10	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TRPC6 FAT1 PZP NOTCH3 COL6A2 DZIP1 SLC6A9 MYOF KCNT2 PRELP	4.70e-08	200	213	10	f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCell	Control_saline-Mesenchymal_myocytic\|Control_saline / Treatment groups by lineage, cell group, cell type	TRPC6 FAT1 PZP NOTCH3 COL6A2 DZIP1 SLC6A9 MYOF KCNT2 PRELP	4.70e-08	200	213	10	5ed4261157cd51109b314818133ac3a0d34ee5fa
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TRPC6 FAT1 PZP NOTCH3 COL6A2 DZIP1 SLC6A9 MYOF KCNT2 PRELP	4.70e-08	200	213	10	67dcbd86fbc79fd585d0793f979e4aac100326c9
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	TRPC6 FAT1 PCDH11X PZP NOTCH3 COL6A2 DZIP1 MYOF KCNT2 PRELP	4.70e-08	200	213	10	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	LPS_IL1RA-Mesenchymal_myocytic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TRPC6 FAT1 PZP NOTCH3 COL6A2 DZIP1 SLC6A9 MYOF KCNT2 PRELP	4.70e-08	200	213	10	77631c471cc5d453a749784f838cfa6408caf09b
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	A2M BNC2 MAMDC2 DZIP1 KCNT2 DACH2 PRELP ROBO1 PRDM6	2.24e-07	180	213	9	01f2e5d96016823482f89ba503d007d4bd88eeac
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FAT1 COL6A2 COL7A1 KCNT2 DACH2 LRP4 ROBO1 OSMR PRDM6	2.46e-07	182	213	9	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	A2M INPP4B ST6GAL2 HMCN2 YAP1 NOTCH3 MYOF FRY KIF13A	2.57e-07	183	213	9	818fd886e0188091310825f9145fa53328f2c979
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC91 EXPH5 TRPC6 F5 FRY KCNT2 TENM3 DACH2 ROBO1	2.57e-07	183	213	9	7c4b775f351794a3de06bd503eecbc8ae8577c44
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	A2M DOCK4 BNC2 TRPC6 MAMDC2 USP53 TENM3 ROBO1 PRDM6	3.09e-07	187	213	9	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	A2M INPP4B ST6GAL2 HMCN2 YAP1 NOTCH3 MYOF FRY KIF13A	3.23e-07	188	213	9	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	COPD-Myeloid-Mast\|Myeloid / Disease state, Lineage and Cell class	A2M BNC2 COBL PZP GCSAML FAM171A1 LRP4 TANC1 RAPGEF2	3.53e-07	190	213	9	379dbac19110b76079a7a53209569e060a852acb
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 COL6A2 PAPLN HIVEP3 MYOF TENM3 ROBO1 OSMR PRDM6	3.53e-07	190	213	9	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRPC6 FAT1 PZP NOTCH3 COL6A2 MYOF KCNT2 PRELP PRDM6	3.69e-07	191	213	9	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRPC6 FAT1 PZP NOTCH3 COL6A2 KCNT2 PRELP LRP4 PRDM6	3.86e-07	192	213	9	992d08092edbc68c47b945deb8708379738c239a
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	A2M BNC2 FAT1 MAMDC2 DZIP1 DACH2 LRP4 ROBO1 PRDM6	3.86e-07	192	213	9	72881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	A2M DOCK4 BNC2 MAMDC2 USP53 COL6A2 HIVEP3 ROBO1 PRDM6	4.03e-07	193	213	9	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	A2M BNC2 TRPC6 MAMDC2 COL6A2 TENM3 PRELP ROBO1 PRDM6	4.03e-07	193	213	9	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	A2M BNC2 TRPC6 INPP4B MAMDC2 USP53 COL6A2 ROBO1 PRDM6	4.39e-07	195	213	9	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FILIP1 INPP4B COL6A2 KCNT2 TENM3 DACH2 TANC1 OSMR	4.59e-07	196	213	9	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M FAT1 KIAA1549L YAP1 NOTCH3 COL6A2 TNS2 TANC1 OSMR	4.79e-07	197	213	9	c165c6fd12dc649b39e920d8528e2eb65c61956b
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M BNC2 TRPC6 MAMDC2 COL6A2 KCNT2 TENM1 ROBO1 PRDM6	4.79e-07	197	213	9	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	A2M BNC2 YAP1 USP53 COL6A2 KCNT2 TENM3 ROBO1 PRDM6	4.79e-07	197	213	9	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	A2M DOCK4 BNC2 YAP1 HIVEP3 TENM3 ROBO1 TANC1 PRDM6	4.79e-07	197	213	9	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	A2M BNC2 TRPC6 MAMDC2 COL6A2 TENM3 PRELP ROBO1 PRDM6	4.99e-07	198	213	9	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	A2M BNC2 TRPC6 MAMDC2 USP53 COL6A2 PRELP ROBO1 PRDM6	4.99e-07	198	213	9	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	343B-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	A2M DOCK4 FILIP1 SPTBN1 MAMDC2 USP53 CD14 PRELP TANC1	5.21e-07	199	213	9	212e89d097753790061310373a1fafba773488b6
ToppCell	343B-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	A2M DOCK4 FILIP1 SPTBN1 MAMDC2 USP53 CD14 PRELP TANC1	5.21e-07	199	213	9	14b676aa289c0578a37be32cec3ea285c79d97cc
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	INPP4B FAT1 PZP NOTCH3 COL6A2 PPP1R3A SLC6A9 MYOF KCNT2	5.43e-07	200	213	9	9169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TRPC6 FAT1 PZP NOTCH3 COL6A2 SLC6A9 MYOF KCNT2 PRELP	5.43e-07	200	213	9	4e1e19214aeebbdca004de7faaf4cc9d18498591
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TRPC6 FAT1 NOTCH3 COL6A2 DZIP1 SLC6A9 MYOF KCNT2 PRELP	5.43e-07	200	213	9	786f1ae53e60b5ffbf4bfd393d10b802478148b3
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_only / Treatment groups by lineage, cell group, cell type	TRPC6 FAT1 PCDH11X NOTCH3 COL6A2 SLC6A9 MYOF KCNT2 ROBO1	5.43e-07	200	213	9	69edc375d85689300d1dbc1217fedc40063ecdcb
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2\|Control_saline / Treatment groups by lineage, cell group, cell type	TRPC6 FAT1 PZP NOTCH3 COL6A2 DZIP1 SLC6A9 KCNT2 PRELP	5.43e-07	200	213	9	bc8949eb34482aca166c4602ff6ab876cb4c2c3c
ToppCell	Biopsy_Other_PF-Epithelial-KRT5-/KRT17+\|Biopsy_Other_PF / Sample group, Lineage and Cell type	MAB21L4 FAT1 SH3RF2 COBL NOTCH3 COL7A1 EDN2 LY6D CDH3	5.43e-07	200	213	9	077e6b9340686de9d0f11b035a8954e1f6a1b790
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M DOCK4 BNC2 TRPC6 MAMDC2 COL6A2 TENM3 ROBO1 PRDM6	5.43e-07	200	213	9	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte\|Control_saline / Treatment groups by lineage, cell group, cell type	TRPC6 FAT1 PZP NOTCH3 COL6A2 DZIP1 SLC6A9 KCNT2 PRELP	5.43e-07	200	213	9	cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M BNC2 TRPC6 MAMDC2 PCDH11X DZIP1 KCNT2 TANC1	2.00e-06	174	213	8	f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	ELFN2 INO80D DSCAML1 DNAAF9 FAM171A1 VPS13D MARF1 KIF13A	2.27e-06	177	213	8	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 TRPC6 F5 FRY KCNT2 TENM3 DACH2 ROBO1	2.91e-06	183	213	8	848fc6dd129150897ee339343e83c645b6e779eb
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M DSCAML1 FAT1 PCDH11X TENM1 ROBO1 ROS1 MYO15A	3.03e-06	184	213	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M DSCAML1 FAT1 PCDH11X TENM1 ROBO1 ROS1 MYO15A	3.03e-06	184	213	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRPC6 FAT1 NOTCH3 COL6A2 PAPLN SLC6A9 MYOF KCNT2	3.03e-06	184	213	8	102b6f621a5b551e622f97b12d787c080b052a72
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M DSCAML1 FAT1 PCDH11X TENM1 ROBO1 ROS1 MYO15A	3.03e-06	184	213	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRPC6 INPP4B FAT1 NOTCH3 PPP1R3A SLC6A9 KCNT2 PRDM6	3.28e-06	186	213	8	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	COPD-Myeloid-Mast\|COPD / Disease state, Lineage and Cell class	A2M BNC2 COBL PZP GCSAML FAM171A1 LRP4 RAPGEF2	3.28e-06	186	213	8	def6f0f284acc2154738574c8c5d3d2a5ef1f208
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 F5 FAT1 MYOF FRY KCNT2 TENM3 ROBO1	3.55e-06	188	213	8	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 F5 FAT1 MYOF FRY KCNT2 TENM3 ROBO1	3.55e-06	188	213	8	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FILIP1 INPP4B COL6A2 KCNT2 TENM3 ROBO1 TANC1	3.69e-06	189	213	8	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	Mesenchymal-myofibroblast_cell\|World / Lineage, Cell type, age group and donor	BNC2 FAT1 COL6A2 DZIP1 KCNT2 DACH2 ROBO1 PRDM6	3.69e-06	189	213	8	44e37f88137bb249933eb615235b2cf2ae7f3925
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FILIP1 INPP4B COL6A2 KCNT2 TENM3 ROBO1 TANC1	3.69e-06	189	213	8	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	IPF-Epithelial-Basal\|IPF / Disease state, Lineage and Cell class	TRPC6 FAT1 SH3RF2 YAP1 COL7A1 TANC1 OSMR CDH3	3.84e-06	190	213	8	ea19e9ce954f2dfde97388db9695325cd92ab88f
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	A2M BNC2 MAMDC2 USP53 COL6A2 TENM3 ROBO1 PRDM6	3.84e-06	190	213	8	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	A2M BNC2 TRPC6 MAMDC2 USP53 TENM3 ROBO1 PRDM6	3.99e-06	191	213	8	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	IPF-Epithelial-Basal\|World / Disease state, Lineage and Cell class	TRPC6 FAT1 SH3RF2 YAP1 COL7A1 LY6D TANC1 CDH3	4.15e-06	192	213	8	9b91e0b162e6f3ce86dd15cc33c2e745d069581f
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 PZP COL6A2 PAPLN HIVEP3 TENM3 ROBO1 OSMR	4.15e-06	192	213	8	df1545670370fb1010c567cd059c2783eab315f7
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FILIP1 INPP4B COL6A2 KCNT2 TENM3 DACH2 PRELP	4.31e-06	193	213	8	f1199518c3626fd29bfce65070dd21a660671213
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	A2M BNC2 YAP1 MAMDC2 KCNT2 DACH2 ROBO1 PRDM6	4.31e-06	193	213	8	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	A2M DOCK4 BNC2 MAMDC2 USP53 COL6A2 HIVEP3 PRDM6	4.31e-06	193	213	8	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	A2M DOCK4 TRPC6 INPP4B MAMDC2 COL7A1 ROBO1 TANC1	4.31e-06	193	213	8	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	A2M DOCK4 BNC2 MAMDC2 USP53 COL6A2 HIVEP3 PRDM6	4.48e-06	194	213	8	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 PZP COL6A2 MYOF TENM3 ROBO1 OSMR PRDM6	4.48e-06	194	213	8	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	BNC2 MAMDC2 CEP126 USP53 COL6A2 KCNT2 PRELP ROBO1	4.48e-06	194	213	8	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FILIP1 INPP4B NOTCH3 COL6A2 FRY KCNT2 PRDM6	4.48e-06	194	213	8	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	F5 HMCN2 VNN1 IL17RA ITIH6 CSF3R LRP4 MYO15A	4.65e-06	195	213	8	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M FILIP1 INPP4B NOTCH3 COL6A2 KCNT2 TENM3 PRELP	4.65e-06	195	213	8	edd4cd8402af81737b2074f9dce71cc6ab09be7e
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	A2M BNC2 TRPC6 MAMDC2 USP53 COL6A2 ROBO1 PRDM6	4.65e-06	195	213	8	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	F5 HMCN2 VNN1 IL17RA ITIH6 CSF3R LRP4 MYO15A	4.65e-06	195	213	8	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	F5 FAT1 MAMDC2 FLG COL6A2 PAPLN MYOF KCNT2	4.83e-06	196	213	8	34e79918a448f6c19b87e1b1ce13c012b24be1f8
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	F5 FAT1 MAMDC2 FLG COL6A2 PAPLN MYOF KCNT2	4.83e-06	196	213	8	8f82e01ca50aa4cd6149547505b4474a02fad618
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	A2M BNC2 MAMDC2 USP53 COL6A2 PRELP ROBO1 PRDM6	4.83e-06	196	213	8	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	DOCK4 POF1B PZP PIGO COL6A2 TENM3 IKBKE LRP4	5.20e-06	198	213	8	0c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	F5 FAT1 MAMDC2 FLG COL6A2 MYOF KCNT2 TENM3	5.40e-06	199	213	8	b9338b739162cd8e5661c9a4dcb41a31219b5723
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	CLSTN3 MYCBP2 PZP COL6A2 HIVEP3 MYOF TENM3 OSMR	5.40e-06	199	213	8	fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TRPC6 FAT1 MAMDC2 PZP COL6A2 DZIP1 LRP4 ROBO1	5.40e-06	199	213	8	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	F5 FAT1 MAMDC2 FLG COL6A2 MYOF KCNT2 TENM3	5.40e-06	199	213	8	c972d3036151403f26fa9d6271520639c281ab84
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	A2M FAT1 YAP1 MAMDC2 NOTCH3 TENM3 TANC1 OSMR	5.40e-06	199	213	8	bf138cc692df727e087d140c014149ee5da00d9d
ToppCell	distal-mesenchymal-Pericyte-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	A2M TRPC6 INPP4B FAT1 NOTCH3 COL6A2 SLC6A9 PRELP	5.40e-06	199	213	8	000d9b5f5a48e56f0733390adb3d7270c49a4a1a
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	A2M FAT1 YAP1 MAMDC2 NOTCH3 TENM3 TANC1 OSMR	5.40e-06	199	213	8	d65ee89d5c7e8ed693d58e6a6de09565840e11c5
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	A2M BNC2 TRPC6 COL6A2 KCNT2 TENM3 ROBO1 PRDM6	5.40e-06	199	213	8	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FILIP1 EXPH5 UNC13D DSCAML1 SH3RF2 PCDH11X COBL MYOF	5.40e-06	199	213	8	a270630626df614f8605abddb7dee7c4d74f6149
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	A2M TRPC6 INPP4B FAT1 NOTCH3 TNS2 SLC6A9 TANC1	5.60e-06	200	213	8	0c648941447c738caf62f2d71e296d6cca492c8b
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M FAT1 MAMDC2 NOTCH3 COL6A2 TENM3 LRP4 OSMR	5.60e-06	200	213	8	16a7c398626b6e82b394eb3ef013bda3a788659d
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M BNC2 DSCAML1 ITIH6 FRY KCNT2 TENM3 PRELP	5.60e-06	200	213	8	f5bd0b30e478dac09f68c46b0781f5f2e7e3c693
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	A2M TRPC6 INPP4B FAT1 NOTCH3 TNS2 SLC6A9 TANC1	5.60e-06	200	213	8	522a51a284d2992d519c4669e1a48c8ebcc08c80
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M BNC2 MAMDC2 COL6A2 KCNT2 PRELP TENM1 PRDM6	5.60e-06	200	213	8	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M BNC2 TRPC6 MAMDC2 COL6A2 TENM3 PRELP PRDM6	5.60e-06	200	213	8	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	A2M TRPC6 INPP4B FAT1 NOTCH3 TNS2 SLC6A9 TANC1	5.60e-06	200	213	8	94f1fa61aa82eb9f411b2b1cb759476939ab5db7
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M TRPC6 CEP126 COL6A2 DZIP1 KCNT2 TENM1 PRDM6	5.60e-06	200	213	8	fb53be20392a8309a7393774c774a1b1aec6e676
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M BNC2 TRPC6 MAMDC2 COL6A2 KCNT2 TENM1 PRDM6	5.60e-06	200	213	8	58b38f9a484ee94191091a0659ed62ebed2d4a14
Drug	S-TDCM	IRF3 NCAPG2 PZP CD14 TLR3 YME1L1	2.47e-06	42	213	6	CID000125053
Disease	pneumonia	HLA-DQB1 HLA-DQB2 F5 MICA FAM171A1	1.95e-05	47	207	5	EFO_0003106
Disease	cervical carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3	HLA-DQB1 HLA-DQB2 MICA	3.94e-05	10	207	3	EFO_0001061, EFO_1000166
Disease	male infertility due to globozoospermia (implicated_via_orthology)	HSP90B1 HSP90B2P	4.90e-05	2	207	2	DOID:0112312 (implicated_via_orthology)
Disease	Syndactyly Cenani Lenz type	APC LRP4	4.90e-05	2	207	2	C1859309
Disease	asthma, seasonal allergic rhinitis	CCDC91 HLA-DQB1 HLA-DQB2 TLR1	7.25e-05	32	207	4	EFO_0003956, MONDO_0004979
Disease	chronic hepatitis C virus infection	HLA-DQB1 HLA-DQB2 MICA DNAAF9	8.21e-05	33	207	4	EFO_0004220
Disease	C-C motif chemokine 19 measurement	HLA-DQB1 HLA-DQB2 DNAJC13	1.17e-04	14	207	3	EFO_0008047
Disease	oligoclonal band measurement, multiple sclerosis	HLA-DQB1 HLA-DQB2 PRKRA	1.17e-04	14	207	3	EFO_0005206, MONDO_0005301
Disease	Graves disease, thyrotoxic periodic paralysis	HLA-DQB1 HLA-DQB2 MICA	2.15e-04	17	207	3	EFO_0004237, MONDO_0019201
Disease	perinatal necrotizing enterocolitis (biomarker_via_orthology)	TLR6 TLR1 TLR3	2.15e-04	17	207	3	DOID:8677 (biomarker_via_orthology)
Disease	Liver carcinoma	A2M HJURP INPP4B YAP1 MICA PZP NOTCH3 APC SHH ARID2 ROBO1 AADAT	2.65e-04	507	207	12	C2239176
Disease	Graves disease	HLA-DQB1 HLA-DQB2 TSHR MICA NECTIN3	2.69e-04	81	207	5	EFO_0004237
Disease	Autoimmune thyroiditis	TSHR ZFAT	2.91e-04	4	207	2	C0920350
Disease	Eczema	FLG CD14	2.91e-04	4	207	2	C0013595
Disease	type 1 diabetes mellitus, latent autoimmune diabetes in adults	HLA-DQB1 HLA-DQB2	2.91e-04	4	207	2	EFO_0009706, MONDO_0005147
Disease	Abnormality of refraction	CCDC91 PKD1L1 DSCAML1 CCDC66 COBL PZP KPNA2 DNAJC13 IGSF11 HIVEP3 FRY ARID2 ROBO1 CCAR2	3.10e-04	673	207	14	HP_0000539
Disease	Autoimmune Hepatitis	HLA-DQB1 HLA-DQB2 MICA	4.12e-04	21	207	3	EFO_0005676
Disease	bone density	HLA-DQB1 HLA-DQB2 SPTBN1 COBL AMBRA1 DACH2 LRP4 STARD3NL MYO15A LRIF1	4.45e-04	388	207	10	EFO_0003923
Disease	toll-like receptor 1 measurement	PIKFYVE TLR1	4.83e-04	5	207	2	EFO_0803159
Disease	narcolepsy-cataplexy syndrome, age at onset	HLA-DQB1 HLA-DQB2	4.83e-04	5	207	2	EFO_0004847, MONDO_0016158
Disease	Herpetic Acute Necrotizing Encephalitis	IRF3 TLR3	4.83e-04	5	207	2	C0001338
Disease	HPV seropositivity	HLA-DQB1 HLA-DQB2	4.83e-04	5	207	2	EFO_0004510
Disease	level of coiled-coil domain-containing protein 134 in blood serum	HLA-DQB1 HLA-DQB2	4.83e-04	5	207	2	OBA_2044258
Disease	Varicella zoster virus seropositivity	HLA-DQB1 HLA-DQB2	4.83e-04	5	207	2	EFO_0009340
Disease	Herpetic meningoencephalitis	IRF3 TLR3	7.21e-04	6	207	2	C0019385
Disease	antibody measurement, Epstein-Barr virus infection	HLA-DQB1 HLA-DQB2	7.21e-04	6	207	2	EFO_0000769, EFO_0004556
Disease	Pleocytosis	APC CSF3R	7.21e-04	6	207	2	C0151857
Disease	pneumocystosis (biomarker_via_orthology)	HLA-DQB1 HLA-DQB2	7.21e-04	6	207	2	DOID:11339 (biomarker_via_orthology)
Disease	pemphigus	HLA-DQB1 HLA-DQB2	7.21e-04	6	207	2	EFO_1000749
Disease	Leukocytosis	APC CSF3R	7.21e-04	6	207	2	C0023518
Disease	eosinophil percentage of leukocytes	BNC2 HLA-DQB1 HLA-DQB2 MICA IL17RA KPNA2 ZFAT NR3C1 PPP1R3A HIVEP3 CMIP CSF3R IKBKE PRKDC	8.50e-04	746	207	14	EFO_0007991
Disease	asthma (is_implicated_in)	HLA-DQB1 TLR6 NR3C1 CD14 TLR1 TLR3	8.70e-04	157	207	6	DOID:2841 (is_implicated_in)
Disease	allergic sensitization measurement	HLA-DQB1 HLA-DQB2 MICA TLR1	9.55e-04	62	207	4	EFO_0005298
Disease	tuberculosis (is_implicated_in)	HLA-DQB1 TLR6 TLR1	9.79e-04	28	207	3	DOID:399 (is_implicated_in)
Disease	peripheral vascular disease	F5 KIAA1549L	1.00e-03	7	207	2	EFO_0003875
Disease	antinuclear antibody measurement	HLA-DQB1 HLA-DQB2	1.00e-03	7	207	2	EFO_0005949
Disease	Anti-Helicobacter pylori IgG measurement	HLA-DQB1 HLA-DQB2	1.00e-03	7	207	2	EFO_0009352
Disease	Herpes encephalitis	IRF3 TLR3	1.00e-03	7	207	2	C0276226
Disease	aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology)	GGT3P GGT2P	1.00e-03	7	207	2	DOID:5022 (biomarker_via_orthology)
Disease	MHC class I polypeptide-related sequence B measurement	HLA-DQB1 HLA-DQB2 MICA	1.20e-03	30	207	3	EFO_0008234
Disease	IgA glomerulonephritis (is_implicated_in)	HLA-DQB1 CD14 TLR1	1.20e-03	30	207	3	DOID:2986 (is_implicated_in)
Disease	rhinitis (is_implicated_in)	HLA-DQB1 TLR6 CD14	1.20e-03	30	207	3	DOID:4483 (is_implicated_in)
Disease	IgG index	HLA-DQB1 HLA-DQB2	1.33e-03	8	207	2	EFO_0006929
Disease	alcohol dependence (biomarker_via_orthology)	GGT3P GGT2P	1.33e-03	8	207	2	DOID:0050741 (biomarker_via_orthology)
Disease	aspergillosis (is_implicated_in)	TLR6 TLR1	1.33e-03	8	207	2	DOID:13564 (is_implicated_in)
Disease	PAX-interacting protein 1 measurement	HLA-DQB1 HLA-DQB2	1.33e-03	8	207	2	EFO_0801868
Disease	Microphthalmia associated with colobomatous cyst	SHH TENM3	1.33e-03	8	207	2	C2931501
Disease	soluble CD163 measurement	HLA-DQB1 HLA-DQB2	1.33e-03	8	207	2	EFO_0020072
Disease	gdnf family receptor alpha-1 measurement	HLA-DQB1 HLA-DQB2	1.33e-03	8	207	2	EFO_0020400
Disease	coloboma (implicated_via_orthology)	YAP1 DZIP1	1.33e-03	8	207	2	DOID:12270 (implicated_via_orthology)
Disease	ovarian cancer (implicated_via_orthology)	YAP1 APC	1.33e-03	8	207	2	DOID:2394 (implicated_via_orthology)
Disease	dehydroepiandrosterone sulphate measurement	DOCK4 SERBP1 TRPC6 CMIP	1.35e-03	68	207	4	EFO_0007001
Disease	age at menopause	ZNF483 BOD1L1 KPNA2 GTF2A1L CSF3R PRKDC LRRN4 LRIF1	1.38e-03	302	207	8	EFO_0004704
Disease	breast size	CCDC91 DOCK4 ADSL PZP	1.42e-03	69	207	4	EFO_0004884
Disease	Colorectal Carcinoma	CLSTN3 F5 DSCAML1 FAT1 YAP1 PCDH11X PZP PIGO COL7A1 APC HIVEP3 RPAP1 TENM1	1.46e-03	702	207	13	C0009402
Disease	nephrotic syndrome	HLA-DQB1 HLA-DQB2 CCDC66 MICA	1.58e-03	71	207	4	EFO_0004255
Disease	allergic disease, age at onset	HLA-DQB1 HLA-DQB2 FLG TLR1	1.58e-03	71	207	4	EFO_0004847, MONDO_0005271
Disease	lupus nephritis	HLA-DQB1 HLA-DQB2 HIVEP3	1.59e-03	33	207	3	EFO_0005761
Disease	zinc fingers and homeoboxes protein 3 measurement	HLA-DQB1 HLA-DQB2	1.71e-03	9	207	2	EFO_0803299
Disease	mitral valve prolapse (is_implicated_in)	TSHR DZIP1	1.71e-03	9	207	2	DOID:988 (is_implicated_in)
Disease	Epstein Barr virus nuclear antigen 1 IgG measurement	HLA-DQB1 HLA-DQB2	1.71e-03	9	207	2	EFO_0007790
Disease	inclusion body myositis	HLA-DQB1 HLA-DQB2	1.71e-03	9	207	2	EFO_0007323
Disease	head and neck malignant neoplasia	HLA-DQB1 HLA-DQB2	1.71e-03	9	207	2	EFO_0006859
Disease	HLA class II histocompatibility antigen, DQ alpha 2 chain measurement	HLA-DQB1 HLA-DQB2	1.71e-03	9	207	2	EFO_0801686
Disease	seropositivity measurement	HLA-DQB1 HLA-DQB2	1.71e-03	9	207	2	EFO_0007034
Disease	latent autoimmune diabetes in adults, type 2 diabetes mellitus	HLA-DQB1 HLA-DQB2	1.71e-03	9	207	2	EFO_0009706, MONDO_0005148
Disease	hyperthyroidism	HLA-DQB1 HLA-DQB2 TSHR	1.89e-03	35	207	3	EFO_0009189
Disease	posterior thigh muscle fat infiltration measurement	HMCN2 IQCN CCDC87	1.89e-03	35	207	3	EFO_0020934
Disease	celiac disease (is_implicated_in)	HLA-DQB1 CD14	2.12e-03	10	207	2	DOID:10608 (is_implicated_in)
Disease	peptidoglycan recognition protein 1 measurement	HLA-DQB1 HLA-DQB2	2.12e-03	10	207	2	EFO_0020624
Disease	CCL19 measurement	HLA-DQB1 HLA-DQB2	2.12e-03	10	207	2	EFO_0009415
Disease	secreted and transmembrane protein 1 measurement	HLA-DQB1 HLA-DQB2	2.12e-03	10	207	2	EFO_0021852
Disease	cortical thickness	CCDC91 A2M BNC2 MYCBP2 SPTBN1 MAST2 BBS9 ZNF469 AGAP3 SHH DNAAF9 RAB44 VPS13D LRP4 ROBO1 OSMR KIF13A	2.30e-03	1113	207	17	EFO_0004840
Disease	asthma, allergic disease	HLA-DQB1 HLA-DQB2 TLR6 TLR1	2.34e-03	79	207	4	MONDO_0004979, MONDO_0005271
Disease	age of onset of asthma	HLA-DQB1 HLA-DQB2 TLR6 TLR1	2.34e-03	79	207	4	OBA_2001001
Disease	allergic disease	HLA-DQB1 HLA-DQB2 MICA FLG IKBKE TLR1 PRDM6	2.39e-03	258	207	7	MONDO_0005271
Disease	lymphoid leukemia	HLA-DQB1 HLA-DQB2 SP140L	2.40e-03	38	207	3	EFO_0004289
Disease	chronic bronchitis	HLA-DQB1 HLA-DQB2	2.58e-03	11	207	2	EFO_0006505
Disease	apolipoprotein M measurement	HLA-DQB1 HLA-DQB2	2.58e-03	11	207	2	EFO_0021945
Disease	cAMP-specific 3',5'-cyclic phosphodiesterase 4D measurement	HLA-DQB1 HLA-DQB2	2.58e-03	11	207	2	EFO_0020224
Disease	head and neck squamous cell carcinoma	HLA-DQB1 HLA-DQB2	2.58e-03	11	207	2	EFO_0000181
Disease	uveitis (implicated_via_orthology)	HLA-DQB1 HLA-DQB2	2.58e-03	11	207	2	DOID:13141 (implicated_via_orthology)
Disease	non-melanoma skin carcinoma	BNC2 HLA-DQB1 HLA-DQB2 IRF3 ZNF469 MICA MYO15A	2.78e-03	265	207	7	EFO_0009260
Disease	hepatocellular carcinoma	HLA-DQB1 HLA-DQB2 MICA	2.98e-03	41	207	3	EFO_0000182
Disease	response to antihypertensive drug	HLA-DQB1 HLA-DQB2 RAPGEF2	2.98e-03	41	207	3	EFO_0005405
Disease	risk-taking behaviour	BNC2 HLA-DQB1 HLA-DQB2 TRPC6 CDK19 INPP4B CEP126 KPNA2 GTF2A1L IGSF11 HIVEP3 KCNT2 LRP4	3.03e-03	764	207	13	EFO_0008579
Disease	systemic scleroderma	HLA-DQB1 HLA-DQB2 TRPC6 IGHM	3.06e-03	85	207	4	EFO_0000717
Disease	rac GTPase-activating protein 1 measurement	HLA-DQB1 HLA-DQB2	3.09e-03	12	207	2	EFO_0801985
Disease	autoimmune thyroiditis (is_implicated_in)	HLA-DQB1 ZFAT	3.09e-03	12	207	2	DOID:7188 (is_implicated_in)
Disease	volumetric bone mineral density	CCDC91 SPTBN1 STARD3NL	3.19e-03	42	207	3	EFO_0007620
Disease	liver cirrhosis (is_implicated_in)	HLA-DQB1 F5 TLR3	3.42e-03	43	207	3	DOID:5082 (is_implicated_in)
Disease	cup-to-disc ratio measurement	BNC2 HLA-DQB1 HLA-DQB2 F5 ELFN2 KIAA1549L PRDM4 TET1 HERC4	3.51e-03	430	207	9	EFO_0006939
Disease	rheumatoid arthritis, smoking status measurement, ACPA-positive rheumatoid arthritis	HLA-DQB1 HLA-DQB2	3.63e-03	13	207	2	EFO_0000685, EFO_0006527, EFO_0009459
Disease	T-cell surface glycoprotein CD3 epsilon chain measurement	F5 PIKFYVE	3.63e-03	13	207	2	EFO_0802114
Disease	Genetic chronic primary adrenal insufficiency	HLA-DQB1 HLA-DQB2	3.63e-03	13	207	2	Orphanet_101960
Disease	neutrophil count	BNC2 HSP90B2P MYCBP2 HLA-DQB1 HLA-DQB2 SPTBN1 TSHR MAST2 ADSL MICA IL17RA USP53 DNAJC13 HIVEP3 CMIP CSF3R LRP4 PRKDC STARD3NL	4.11e-03	1382	207	19	EFO_0004833
Disease	oropharynx cancer	HLA-DQB1 HLA-DQB2 TENM3	4.14e-03	46	207	3	EFO_1001931
Disease	oral cavity cancer	HLA-DQB1 HLA-DQB2	4.22e-03	14	207	2	EFO_0005570
Disease	biliary atresia (is_marker_for)	SHH CD14	4.22e-03	14	207	2	DOID:13608 (is_marker_for)
Disease	liver neoplasm	HLA-DQB1 HLA-DQB2	4.84e-03	15	207	2	EFO_1001513

Protein segments in the cluster

Peptide	Gene	Start	Entry
HSLHLQDSRNASSLP	nan	106	A8MWP4
HHPSRIQVSSEKEAA	CCAR2	276	Q8N163
QTSPFEEHTILTHKQ	C2orf16	666	Q68DN1
SHSAVSAASIPAVHI	AGAP3	271	Q96P47
ENHITEAQRFSHLPK	ABCG4	41	Q9H172
LHIQVSTLHPSTFNQ	AADAT	286	Q8N5Z0
APSRAAVHQLLASVH	C1orf167	421	Q5SNV9
SEAHQILSRSNHPKL	ELMOD2	186	Q8IZ81
IKTSNPFHHDQLDRI	CDK19	241	Q9BWU1
RVAHPSHVLSSQQFL	CLSTN3	806	Q9BQT9
SLLAHLENSNPSSIH	BNC2	296	Q6ZN30
QAIAQPATTAKSHLH	ALKBH3	21	Q96Q83
ALAAVKLIEHPSSSH	ARID2	461	Q68CP9
ELVAHHLSTLQSSLP	CCNI	241	Q14094
PHHLTLADNSLASAT	CMIP	86	Q8IY22
HSLASNRVQHSVAPT	ARL9	36	Q6T311
EQPASSSHAQGTHLR	EDN2	31	P20800
SHVSVAPATLTILHQ	APBB1	581	O00213
DTLTPRDHHTLFSNV	ARHGEF15	451	O94989
HRDTASHVQSSPVQS	FLG	3906	P20930
SSREPLLNHLSDVHN	DEPDC7	311	Q96QD5
FSPDRTLLASTHVNH	AMBRA1	61	Q9C0C7
VRHLVSALKDPHQST	CCDC87	826	Q9NVE4
LHLTPSHKAAEDSTA	DENND1C	681	Q8IV53
LEENHRPGSQTSSHT	DACH2	381	Q96NX9
ATHSSNELFRIVAHP	DMXL1	2336	Q9Y485
QSLPASHAHLRVTAA	A2M	576	P01023
HSATRPQQTSDLHVQ	HJURP	531	Q8NCD3
ASHAHLQVAAAPQSL	PZP	576	P20742
SDNPHVLVDTLTSHS	OSMR	626	Q99650
LSHLRSTHQEAASEN	RAB44	281	Q7Z6P3
LIPAHQAADLSSNTH	IQCN	756	Q9H0B3
SIRNVHSILPQDHTF	MAMDC2	196	Q7Z304
QHPVGTSDHRDATQL	MICA	351	Q29983
DHHFRKPANDITSQL	SERBP1	341	Q8NC51
HLHPIQTSFQEATAS	NUP210	1561	Q8TEM1
SHSVNAHIPQFRSTL	FAT1	706	Q14517
AAQLRSQISDHTTHP	GGT3P	351	A6NGU5
ASQPEAALRIHATHL	MAB21L4	366	Q08AI8
FQSIIHLSLDSPVHA	PADI6	11	Q6TGC4
LLRFQSSHHPADITS	HSP90B2P	166	Q58FF3
SSPKDLQIQLHFAHT	IL17RA	71	Q96F46
LKVHISDASTHQPVA	FAM171A1	36	Q5VUB5
QHLAPLSASTSHINR	LZTS3	236	O60299
LSSITSHLQDPNHLT	KCTD21	171	Q4G0X4
PTSDVSQHNILTSHS	LRIF1	671	Q5T3J3
ISATLHVTSNPVHAA	NFRKB	1006	Q6P4R8
LALPHNTHRVVSTQA	GPAA1	476	O43292
TSGVQSRKHHSLQSP	BLZF1	36	Q9H2G9
SVQPHSTAELALTNH	BLZF1	286	Q9H2G9
TRVVAHLFSSHAPQA	MYO15A	1736	Q9UKN7
THLSPELAAQSVTHI	MMS19	666	Q96T76
VSSIHSSIRHVPANV	HMCN2	4426	Q8NDA2
THADLLLNSASQHSP	INPP4B	426	O15327
QHLSLQVPLRSHSSS	KIAA1109	1216	Q2LD37
LEPSVSAQHIAHTTA	IKBKE	361	Q14164
RQNQSTVAVHSHEPL	ARNTL2	576	Q8WYA1
TISPSRTEALNHHNL	HLA-DQB2	131	P05538
QIQHLNIPSSSSTHS	LUZP6	41	Q538Z0
PSAHELAQNRLHVSI	PNPLA4	101	P41247
VSSNPHRASKLTDHN	CUL7	846	Q14999
ISPHRESDHSSLNNK	DDIAS	561	Q8IXT1
HNSTSHEINPRKVFE	HERC4	276	Q5GLZ8
NAQDHSGRTPLHTAV	NOTCH3	1866	Q9UM47
ATATHSIAHLVPSQT	NRF1	291	Q16656
HSNASHLATPLDQSV	MYRFL	121	Q96LU7
ANISPSHVATEHTLN	KIF24	521	Q5T7B8
AQHLTSPSLSHSDIV	LMLN2	286	A0A1B0GTW7
SHSESQVFALTPALH	EXPH5	1501	Q8NEV8
FPKTHSDVSSEQQHL	NR3C1	156	P04150
TADLKQHTPHLQSVA	KIAA1549L	911	Q6ZVL6
HRNSTSSDQSDHPLL	KCNT2	996	Q6UVM3
STQHHSPRVTQTIAL	PCDH11X	1181	Q9BZA7
SAQATPLLHALTAAH	HUWE1	886	Q7Z6Z7
LFHSLAPLLQTSAHQ	NUDT13	51	Q86X67
SDSLQQTLSHRPCHL	POU2F3	51	Q9UKI9
DHSQELHSPTLKIST	POF1B	91	Q8WVV4
TELFTNHRHLTAETP	BBS9	861	Q3SYG4
LLLNHSHNVTTVTPF	MYBBP1A	551	Q9BQG0
LKRHISHQTSVNADP	SMPD4	276	Q9NXE4
QNSSPFSKHHTEISV	PPP1R3A	911	Q16821
SQPSELRNHVVTHSS	PRDM6	511	Q9NQX0
RDLGPTLANSTHHNV	GBA	301	P04062
AFISLLASPHAHISE	KPNA2	166	P52292
PSLVNLHSAHTKLQT	KICS2	211	Q96MD2
RFQSSHHPTDITSLD	HSP90B1	511	P14625
TSKRHIPEAHQATLL	BOD1L1	1361	Q8NFC6
LPQAVASVKHQEHST	PIKFYVE	946	Q9Y2I7
VTISPSRTEALNHHN	HLA-DQB1	131	P01920
VINHIPHQRSSLSSN	GCSAML	71	Q5JQS6
PHSLDLSHNSLRATV	CD14	251	P08571
PKVHRNTESVSHFSD	IGSF11	326	Q5DX21
DLVSHPRATQTHVEA	HEATR5B	336	Q9P2D3
KDTPVQASSHHLFVQ	DOCK4	191	Q8N1I0
AVKTHTNISESHPNA	IGHM	266	P01871
QQSTHTHLDISLFPL	CCDC91	91	Q7Z6B0
TYHTQARHLTLDPAS	DSCAML1	1936	Q8TD84
RSHTNAEHALRNPES	DYTN	441	A2CJ06
NIITHNSFNSKHVLP	CEP126	831	Q9P2H0
NSFNSKHVLPTEHSL	CEP126	836	Q9P2H0
ASSTPESLQARRHHQ	CENPT	401	Q96BT3
AFPLSHNLTAIHEAL	COL6A2	891	P12110
SHHALEIRSSETQQP	COBL	101	O75128
SQNRGISPEIFHSSH	CCDC66	751	A2RUB6
FTSHTTEQRHPLLVQ	DNAAF9	891	Q5TEA3
IITLPHLNHTQAFLS	CSF3R	86	Q99062
AHLHVSRATVPLQSN	DNAJC13	946	O75165
LHNAAPTRTALAHSA	LY6D	96	Q14210
TFAPQVHSLLQTHEG	MARF1	1006	Q9Y4F3
ASATALSLLIPSEHH	MAST2	1051	Q6P0Q8
AHTLVTSVLFNPHAE	ITIH6	51	Q6UXX5
APTTHTIAQARQLSH	INO80D	246	Q53TQ3
SHASQRPHPAQLLSK	INO80D	791	Q53TQ3
SQLHAVPVLRVSHAE	COL7A1	2826	Q02388
GDLSHSPQTAQHVER	CCDC177	306	Q9NQR7
HVAVSDSATLPLTHN	FRY	801	Q5TBA9
VTQKHITLPHFTNTA	CFAP47	2426	Q6ZTR5
AAVDTHRQTLILPSH	PKD1L1	731	Q8TDX9
HFTITTHPESNQGIL	CDH3	376	P22223
TPVNAHSSRSHAVFQ	KIF2B	416	Q8N4N8
AAQLRSQISDHTTHP	GGT2P	351	P36268
LASVATHIFQDTPHL	LRRN4	266	Q8WUT4
DSRSVNTHGAQSLHP	PRDM4	166	Q9UKN5
VDLHISNSHPLSLTS	IRF3	391	Q14653
HPTTILLHKSQSSQA	MROH5	56	Q6ZUA9
DSSVHDSVHLNRVTP	KIF13A	1231	Q9H1H9
HPVQATHRGAVSNSL	RTTN	1996	Q86VV8
HATHLQSTEASVPAK	TGIF2LX	131	Q8IUE1
HTPEHARAVAVTNTL	SPAG6	366	O75602
LTAAHLLFVAPHNDS	SHH	266	Q15465
HATHLQSTEASVPAK	TGIF2LY	131	Q8IUE0
PNASVALHKHSNALV	PSMC4	126	P43686
HSLVLHKSNETSLPT	F5	1066	P12259
HIRVTPDHENSTATL	FILIP1	911	Q7Z7B0
FHHLPQETSRLETNA	RGPD2	461	P0DJD1
LPTATTHSAHLVNDF	SLC25A51	201	Q9H1U9
SSVPKFTHHQNNTIT	PRDM15	696	P57071
IHSQLDHLLDPSSFT	ADSL	436	P30566
VGPAQSSLEEQHRSH	PSD4	916	Q8NDX1
PVLKAHQSHSAEIES	SIKE1	126	Q9BRV8
SQILTNPSHHFIDSS	ST6GAL2	346	Q96JF0
QRDTEASHLAPNHTT	SECISBP2	606	Q96T21
VLHLDHSADSPVSSL	TANC1	31	Q9C0D5
NPIRVTHLYNHTSSE	TENM1	2276	Q9UKZ4
VREEHSSKLQTSLHP	SEMG2	226	Q02383
SSKLQTSLHPAHQDR	SEMG2	231	Q02383
SDSHSRSLSPNHNTL	MYCBP2	2781	O75592
LHLSHNRISSVPAIN	PRELP	296	P51888
LPTATTHSAHLVNDF	SLC25A52	201	Q3SY17
ARHDHAVSLLTAASP	SCRIB	926	Q14160
LKASLHLHVPSVQSD	MED13	2096	Q9UHV7
KHSHPLDSNQTSDVL	MED13	2116	Q9UHV7
HLPAHSQSLQRLFTE	SP140L	26	Q9H930
VSSILPEHHKDFNSQ	SPDYE2B	111	A6NHP3
QLTRSELEAAHHASA	DZIP1	251	Q86YF9
SLSVLIIDHNSVSHP	TLR1	491	Q15399
PLATSTDHGHNLQTV	SPTBN1	1506	Q01082
LNQIPSHKALTLTHD	TET1	2101	Q8NFU7
RFPHHSQLDTLIQVS	ADPRH	141	P54922
ARASAALHNIIHSQP	APC	381	P25054
PLHEFITAVQSRHTD	NCAPG2	986	Q86XI2
SSLSSNHDHLTVPDK	CNK3/IPCEF1	741	G9CGD6
PSALSLSSALHQHSE	C15orf62	111	A8K5M9
DHSVRVLISNHVTPF	AUP1	86	Q9Y679
SSSLQIPKDHNAREH	USP53	796	Q70EK8
TLSSSNPDLLQSHHR	RAPGEF2	581	Q9Y4G8
RAFLPTSHLSDHVAN	PDCD11	661	Q14690
TTHPEVKSHNQSARA	ZNF567	176	Q8N184
LTHDASNIHTSTPRN	WDR47	531	O94967
SPNQSELLSHVSEKH	ZFAT	21	Q9P243
LTNETFVSLAHSPLH	TLR3	396	O15455
PVSSSLTQHVRIHAA	ZNF778	291	Q96MU6
FIQNSALRPHSVTHT	ZNF596	176	Q8TC21
LSQLDSHPSHSAVVN	VNN1	301	O95497
STLANHQRTHTGEKP	ZSCAN20	916	P17040
PHSITQTVSLSHLSQ	SPEN	3081	Q96T58
HLFSAINSHLLTAQP	RINT1	126	Q6NUQ1
SRAVASTVHNTHQPQ	PAPLN	696	O95428
PHSLHQTLQSSTASL	GTF2A1L	71	Q9UNN4
KRASSVLPEHHEAFN	SPDYE4	96	A6NLX3
VSSILPEHHKDFNSQ	SPDYE6	111	P0CI01
QSSHASLRNIHSINP	STARD3NL	16	O95772
THPTQTAFLSSVDLH	STAMBP	336	O95630
RTEENIFSHLPLHSQ	HIVEP3	2171	Q5T1R4
SSNPDLHLNRATLHK	TTC5	221	Q8N0Z6
QHVRAHSSPASLQLG	YAP1	121	P46937
TALSTSKVDHNVPRH	ZNF654	531	Q8IZM8
LSHLLNHSLQRTSPS	SLC6A9	251	P48067
HHPSITSLNRNSLTN	TENM3	196	Q9P273
SHTLHRILQPTATNQ	ROS1	1306	P08922
LSLQPKHHGTDQSRS	USF3	1536	Q68DE3
AVLHLHNPTVLSSSS	ROBO1	676	Q9Y6N7
SSHEVFLQRLSSHPV	SNX5	141	Q9Y5X3
LEHLNHVVSSAPSLR	TMEM201	91	Q5SNT2
PSLVAFLRSHSHTQE	RPAP1	256	Q9BWH6
SSLVQHQSIHTGEKP	ZNF780A	486	O75290
RSGEHTQETNSPHSL	SKOR2	916	Q2VWA4
SLSVLIIDHNSVSHP	TLR6	496	Q9Y2C9
NILPSQSTDLHHSVG	PRKDC	1466	P78527
SPENHISLTNVVGHS	PRKRA	196	O75569
PHTHRTAEAQSDLLS	ZNF469	3891	Q96JG9
QVTVPLSHLINAFHT	YME1L1	11	Q96TA2
PQHLETADASLSKHS	ZNF644	936	Q9H582
FSQSSSLIPHQRIHT	ZFP69B	316	Q9UJL9
TLSHHPSFTLQQIIN	ZNF566	151	Q969W8
PFSDSSSLIQHQRIH	ZNF483	531	Q8TF39
PHSSALAQASALHLN	PIGO	356	Q8TEQ8
HSTAVVSLPGSQQHL	SH3RF2	366	Q8TEC5
EHLQIHTGVPFTSSQ	ZBTB2	271	Q8N680
FRVSSSLPNHQVIHT	ZNF766	196	Q5HY98
HNKQPSIRSSEDFHL	TRPC6	831	Q9Y210
IPHKISSDQLSSEHL	VWA8	1331	A3KMH1
QHIHGTNLSARSSPE	VN1R3	216	Q9BXE9
PQVSAHHRSQESLTS	TBC1D10A	486	Q9BXI6
SSLTLHQRNHTGEKP	ZNF71	311	Q9NQZ8
LTLPEQHRASYSHLS	ZFYVE26	1661	Q68DK2
ASRSQPSYTVHLHLL	UNC13D	291	Q70J99
ISHHVTFAPLLSDNV	TNS2	1101	Q63HR2
LHSSEPQHSLINSTV	ZBTB26	211	Q9HCK0
ETHLRTIPSHAFSNL	TSHR	61	P16473
HHPLQRQLSADAAVT	ELFN2	611	Q5R3F8
NPAHSHFERRLNVST	VPS13D	616	Q5THJ4
AVTRHSPSIHQSVVA	AGL	731	P35573
VLVSHVSHPFALTQQ	LRP4	1551	O75096
HVETRTLHSTFQPNI	MYOF	1741	Q9NZM1
LASDNTLHFVHPLTF	NECTIN3	316	Q9NQS3